A

Angiochem

11 employees

AngioChem develops new drugs that are capable of crossing the blood-brain barrier to treat brain diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Pain
Health Care
Oncology
LSD

Date founded

2003

Funding rounds raised

Total raised

$4M

from 2 investors over 2 rounds

A

Angiochem raised $4M on June 4, 2019

Investors: Gouvernement du Québec – Carrières

A

Angiochem raised $3M on December 1, 2007

Investors: MMV Financial

FAQ